CELYAD ONCOLOGY SA (CYAD) Financial Statements
CELYAD ONCOLOGY SA (CYAD) files with the U.S. Securities and Exchange Commission under CIK 0001637890. 10KGenie shows its annual statements from SEC filings.
Key Figures, Fiscal Year 2022
- Revenue
- 0 EUR
- Net Income
- -40.94 million EUR
- Total Assets
- 19.72 million EUR
- Net Cash from Operations
- -28.01 million EUR
Fiscal year ended Dec 31, 2022. Latest periodic SEC filing: Mar 23, 2023. Source: SEC filings (EDGAR XBRL). Amounts in EUR.
Open the full financial statements for CYAD in 10KGenie
Data from SEC EDGAR filings. 10KGenie is not affiliated with the SEC. SEC Filing History